Asia-Pacific Biological Data Visualization Market to Reach $464.6 Million By 2035

Asia-Pacific biological data visualization market stood at $188.9 million in 2025 and is expected to grow to $464.6 million by 2035, registering a CAGR of 9.5% over the 2026 to 2035 period, according to a new report by OMR Global. National genomics projects and large-scale biological data initiatives in the Asia Pacific are generating vast amounts of genomic and population data that create strong demand for sophisticated visualization tools. Projects such as the Genome India Project, which has completed whole-genome sequencing of 10,000 individuals and archived roughly 700 terabytes of genomic data at India’s national repository, are producing datasets that require advanced platforms for interpretation, integration, and visualization in research, healthcare, and clinical applications. Simultaneously, multi-national efforts like the GenomeAsia 100K Project are cataloguing genetic variation across large, ethnically diverse Asian populations, increasing the volume and complexity of biological data that researchers must visualise and analyse.

Browse the full report description of “Asia-Pacific Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period 2026-2035” of https://www.omrglobal.com/industry-reports/asia-pacific-biological-data-visualization-market

These initiatives reflect a broader trend of public investment in biological data generation and management infrastructure across the region. The Genome India Project alone has made genomic data from 10,000 individuals publicly accessible, with associated phenotype data for over 9,300 samples, which supports research into disease predisposition, drug response, and population genetics. Meanwhile, the GenomeAsia 100K Project’s pilot phase produced high-coverage whole-genome sequences from 1,739 individuals across 219 population groups in Asia, helping fill longstanding gaps in reference datasets for non-European populations. These government and consortium-led efforts significantly expand the data available for genomic analysis, strengthening the case for scalable visualization tools that can integrate multi-dimensional biological information into actionable insights.

Strategic Genomics Collaborations Strengthen Asia-Pacific Sequencing and Bioinformatics Ecosystem

• In April 2025, MGI Tech Co., Ltd. launched the APAC SEQ ALL Alliance during the MGI APAC SEQ ALL Partner Summit held in Bali, Indonesia. The alliance brings together Asia-Pacific institutions such as Gene Solutions, GenePlus, and Genetron to support the development of an open and integrated sequencing technology ecosystem across the region.

• On June 14, 2024, Thermo Fisher Scientific, National University Hospital Singapore, and RNA technology firm Mirxes entered into a memorandum of understanding to advance affordable and region-specific genomic testing for cancer in Southeast Asia. The collaboration focuses on developing and validating next-generation sequencing solutions to improve access to timely genomic diagnostics.

• In December 2025, Thermo Fisher Scientific announced the expansion of its bioprocessing footprint in Asia with the opening of a new Bioprocess Design Center in Hyderabad, India, alongside capacity expansions at existing centers in Incheon, South Korea, and Singapore, strengthening regional life sciences infrastructure.

• In September 2024, Illumina partnered with LGC Biosearch Technologies to advance agricultural genomics across the Asia Pacific region, excluding China, as well as Latin America. The partnership combines Biosearch’s Amp-Seq targeted genotyping-by-sequencing approach with Illumina’s scalable sequencing platforms to support research and breeding applications.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Technique
  • Application
  • End-User
• Competitive Landscape – Agilent Technologies, Inc., Bruker Corp., GE HealthCare Technologies Inc., Illumina, Inc., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Biological Data Visualization Market Report Segment

By Technique

• Magnetic Resonance Imaging
• Microscopy
• Sequencing
• Others

By Application

• Genomic Analysis
• Cell Biology
• Molecular and Structural Analysis
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Clinics

Asia-Pacific Biological Data Visualization Market Report Segment by Country

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-biological-data-visualization-market